Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Secukinumab biosimilar for treating plaque psoriasis	Secukinumab biosimilar (BAT2306)	Plaque psoriasis	Dermatology	2024	View \| Download
Secukinumab for enthesitis-related arthritis and juvenile psoriatic arthritis in children and adolescents from the age of 2 years	Secukinumab (Cosentyx; AIN457)	Enthesitis-related arthritis , Juvenile psoriatic arthritis	Rheumatology	2019	View \| Download
Secukinumab for hidradenitis suppurativa	Secukinumab (Cosentyx; AIN457)	Hidradenitis suppurativa (HS)	Dermatology	2021	View \| Download
Secukinumab for moderate to severe plaque psoriasis in children aged 6 to less than 18 years old	Secukinumab (Cosentyx; AIN457)	Plaque psoriasis	Dermatology	2019	View \| Download
Secukinumab for Non-Radiographic Axial Spondyloarthritis – second or subsequent line	Secukinumab (Cosentyx; AIN457)	Spondyloarthritis	Musculoskeletal System , Rheumatology	2018	View \| Download
Seladelpar for primary biliary cirrhosis – second or subsequent line	Seladelpar (MBX-8025; RWJ-800025)	Primary biliary cholangitis (PBC)	Hepatology	2017	View \| Download
Selinexor for advanced or recurrent endometrial cancer - maintenance therapy	Selinexor (KPT-330; Xpovio)	Endometrial cancer	Female Reproductive Cancer	2020	View \| Download
Selinexor for advanced unresectable dedifferentiated liposarcoma	Selinexor (KPT-330; Xpovio)	Soft tissue sarcoma	Sarcoma	2020	View \| Download
Selinexor in addition to bortezomib and low-dose dexamethasone for relapsed or refractory multiple myeloma	Bortezomib (Velcade; bortezomib mannitol boronic ester) , Dexamethasone (dexamethasone sodium metasulfobenzoate) , Selinexor (KPT-330; Xpovio)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2020	View \| Download
Selinexor in combination with low-dose dexamethasone for penta-refractory multiple myeloma	Dexamethasone (dexamethasone sodium metasulfobenzoate) , Selinexor (KPT-330; Xpovio)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2018	View \| Download